| Dec'19 | Dec'18 | Dec'17 | ||||
|---|---|---|---|---|---|---|
Cash flows from operating activities: | ||||||
Net income (loss) | ||||||
2,499 | 0 | 0 | ||||
Adjustments to reconcile net income(loss) to net cash used in operating activities: | ||||||
Trust account interest income | ||||||
3,651 | 0 | 0 | ||||
Changes in operating assets and liabilities: | ||||||
Decrease (increase) in prepaid expenses | ||||||
20 | 0 | 0 | ||||
Increase (decrease) in accounts payable and accrued liabilities | ||||||
191 | 0 | 0 | ||||
Increase (decrease) in income taxes payable | ||||||
664 | 0 | 0 | ||||
Net cash used in operating activities | ||||||
-316 | 0 | 0 | ||||
Cash flows from investing activities: | ||||||
Cash deposited in trust account | ||||||
316,250 | 0 | 0 | ||||
Net cash provided by investing activities | ||||||
-316,250 | 0 | 0 | ||||
Cash flows from financing activities: | ||||||
Proceeds from public offering | ||||||
316,250 | 0 | 0 | ||||
Proceeds from sale of private placement warrants | ||||||
8,825 | 0 | 0 | ||||
Proceeds from sale of common stock to sponsor | ||||||
10 | 0 | 0 | ||||
Payment for underwriting discounts | ||||||
-6,325 | 0 | 0 | ||||
Payment of offering costs | ||||||
517 | 0 | 0 | ||||
Payment of notes payable, affiliates | ||||||
-83 | 0 | 0 | ||||
Proceeds from stock subscriptions receivable, affiliates | ||||||
1 | 0 | 0 | ||||
Net cash provided by financing activities | ||||||
318,159 | 0 | 0 | ||||
Net decrease in cash and cash equivalents | ||||||
1,593 | 0 | 0 | ||||
Supplemental schedule of non-cash financing activities: | ||||||
Change in value of common shares subject to possible conversion | ||||||
2,533 | 0 | 0 | ||||
Initial classification of common shares subject to possible conversion | ||||||
301,958 | 0 | 0 | ||||
Deferred underwriting commissions | ||||||
11,068 | 0 | 0 | ||||
Accrued offering costs | ||||||
98 | 0 | 0 | ||||
Offering costs included in Notes payable, affiliates | ||||||
83 | 0 | 0 | ||||